Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Pigs in farrowing crates and loose-housing systems showed no difference in chronic stress levels as measured by hair cortisol.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

First-time mothers had higher stress hormone levels in late pregnancy than mothers who had given birth before.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that more research is needed to fully understand the causes of PCOS.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Androgens significantly affect female hair loss, and hormonal treatments may help.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.